Tuberc Respir Dis.
1993 Oct;40(5):474-482.
Effects of the dosing regimen of tissue-type plasminogen activator on blood coagulation system in experimental pulmonary embolism
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Differences in thrombolytic effects in accordance with dosing- resimens of tissue- type plasminogen activator in experimental pulmonary embolism
- The treatment of the pulmonary embolism with tissue plasminogen activator: A case report
- Effect of immune-mediated vascular injury on the coagulation- regulatory mechanism of the human endothelial cells; changes of tissue-type plasminogen activator, plasminogen activator inhibitor- 1 and von Willebrand factor
- Successful thrombolytic therapy with recombinant tissue-type plasminogen activator for massive pulmonary embolism: A case report
- Pulmonary Embolism in Lupus Anticoagulant Positive Postmenopausal Woman after Estrogen Replacement Therapy
